Giulia De Angelis, Tiziana D’Inzeo, Barbara Fiori, Teresa Spanu and Gabriele Sganga
Infections due to antibiotic-resistant Gram-negative bacteria unquestionably have substantial effects on morbidity and mortality. However, quantifying the exact economic burden attributable to these infections still remains a challenging issue. The review of the literature on this subject shows that severe infections from Gram-negative bacteria are associated with increased economic burden. However, the low comparability of methods and results limit the possibility to draw a clear conclusion. A better collaboration between health economy and clinical research is advocated to produce specific guidelines for economic studies in medical research.
PDFShare this article
Medical Microbiology & Diagnosis received 14 citations as per Google Scholar report
